A research study to compare blood levels of cagrilintide after multiple doses of
different versions of cagrilintide in adults with overweight or obesity
Фаза 4 – наблюдение след одобрението на пазара
Заболявания:
obesity
Спонсор: Novo Nordisk A/S
Налично на:
БГ
Обобщение
Trial status: Authorised
Кой може да участва
Age group: 18-64 years
Gender: Female, Male
Target enrollment: 234 participants
БГ
EN